~~<i id='2418D35F46'><strike id='2418D35F46'><tt id='2418D35F46'><pre id='2418D35F46'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

author：explore 2025-09-06 10:34:17 Page View：4824

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Latest bird flu infection made farmworker sicker than earlier cases
Next article： Trump demands the U.S. pay no more for drugs than other countries … again

leisure time

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

Mike Pence clashes with Tucker Carlson in Iowa

3:09TuckerCarlson,left,andformerVicePresidentMikePenceGettyImagesFormerFoxNewshostTuckerCarlsonclash

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

Who gets to use the title 'doctor'?

AdobeFloridalegislatorsrecentlypassedlegislationtopreventadvancedpracticenursesinFloridawithdoctorat